WHO ICTRP trial
Effect of tranexamic acid on coronary perfusion
IRCT20180724040575N3 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20180724040575N3 |
|---|---|
| Public title | Effect of tranexamic acid on coronary perfusion |
| Scientific title | Comparison of different doses of tranexamic acid on coronary perfusion in patients undergoing coronary artery bypass graft surgery (CABG) |
| Primary sponsor | Shahid Beheshti University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Coronary artery bypass graft surgery. |
| Interventions | Intervention 1: Intervention group: Patients undergoing coronary artery bypass graft receiving a high dose of tranexamic acid. In this group, after induction of anesthesia, tranexamic acid drug made by Caspian Pharmaceutical Company (500 mg… |
| Registration date | Sep 29, 2020 |
| Target size | 120 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: